Biomarker: | No biomarker |
---|---|
Cancer: | Acute Myelogenous Leukemia |
Drug: | cytarabine (DNA synthesis inhibitor, DNA-directed DNAP inhibitor) + idarubicin hydrochloride (Topoisomerase II inhibitor, DNA cross linking agent) + cladribine (Purinergic receptor P1 agonist) |
Direction: | Sensitive |